Urinary biomarker profiling in transitional cell carcinoma. - Wikidata - wikimedia - TriplyDB

Urinary biomarker profiling in transitional cell carcinoma.

Urinary biomarker profiling in transitional cell carcinoma.

http://www.wikidata.org/entity/Q51932949

about

Discovery and validation of urinary biomarkers for prostate cancer A method for improving SELDI-TOF mass spectrometry data quality.SELDI-TOF MS whole serum proteomic profiling with IMAC surface does not reliably detect prostate cancer Increased hepcidin expression in colorectal carcinogenesis.Integrated multi-level quality control for proteomic profiling studies using mass spectrometry.Approaching clinical proteomics: current state and future fields of application in fluid proteomics.Association of serum amyloid A protein and peptide fragments with prognosis in renal cancer.High-resolution proteome/peptidome analysis of peptides and low-molecular-weight proteins in urine Proteomic patterns analysis with multivariate calculations as a promising tool for prompt differentiation of early stage lung tissue with cancer and unchanged tissue material.SELDI-TOF-MS proteomic profiling of serum, urine, and amniotic fluid in neural tube defects.Assessment of high-throughput high-resolution MALDI-TOF-MS of urinary peptides for the detection of muscle-invasive bladder cancer.Data mining in the Life Sciences with Random Forest: a walk in the park or lost in the jungle?An empirical assessment of validation practices for molecular classifiers Discrimination of normal and esophageal cancer plasma proteomes by MALDI-TOF mass spectrometry.Statistical considerations of optimal study design for human plasma proteomics and biomarker discovery Proteomic study of benign and malignant pleural effusion.Proteomic analysis of formalin-fixed paraffin-embedded pancreatic tissue using liquid chromatography tandem mass spectrometry Proteomic profiling of urine for the detection of colon cancer.Detection of tumours of the urinary tract in voided urine.Molecular markers for detection, surveillance and prognostication of bladder cancer.High throughput molecular diagnostics in bladder cancer - on the brink of clinical utility.Mass spectrometry based proteomics profiling as diagnostic tool in oncology: current status and future perspective.Methods for the discovery of low-abundance biomarkers for urinary bladder cancer in biological fluids.Mass spectrometry-based proteomics of endoscopically collected pancreatic fluid in chronic pancreatitis research Urine proteomics in kidney and urogenital diseases: Moving towards clinical applications.A proteomic comparison of formalin-fixed paraffin-embedded pancreatic tissue from autoimmune pancreatitis, chronic pancreatitis, and pancreatic cancer.Optimized sample preparation of endoscopic collected pancreatic fluid for SDS-PAGE analysis

P2860

Q30438582-37B662D4-1E56-44C5-A7FD-094216FF2E93 Q31125985-24D34825-44AE-4DE6-BDF2-A9795D6E40EE Q33306300-A5066DE8-52C1-40F0-AAA9-F92693E8F183 Q33322690-7F3236E6-217C-4F85-A534-D89E139AFFB3 Q33389590-21A55D32-091A-46F8-96F3-37CB71C6051E Q33467523-05384D2B-89E1-4EFE-A914-42407C2F9817 Q33597715-71AEDDD7-721B-4A68-8AB3-BA9C4CFA9ABC Q33610197-C143BA65-2195-4B7A-9CEB-9ED06B299AF8 Q33850368-64E800C3-B5C7-4FDD-A105-C87F9B174F3C Q33940289-E974FD92-D2E4-402A-AB54-671DA006B578 Q33976936-0460431C-E98E-475D-971D-8D05552FBA07 Q34333936-963002DD-33A7-4F0A-83BE-348BBE490C04 Q34933977-2FF518CD-1B89-4283-AC67-F64F241675D9 Q35541147-6443EB2C-697C-4651-BD9A-402BFDD059B3 Q35873957-0FDC9F8C-B355-4173-9E32-4E8EFE763B14 Q35946652-65DC3F94-CACB-47E9-910D-752671B03547 Q36011264-B30D6B4D-6444-4213-805E-445E51E1C09E Q36736959-C0DEE869-F1E2-4F7B-9BE6-7CB6D228E695 Q37278998-2A83F6B4-F4C0-4C33-A590-B320B1CDF865 Q37418122-F24E407E-D97C-44D0-B08E-505FE8AEDE95 Q37453816-DF1FC39E-4338-47F9-A319-D4FBFD948175 Q37484011-4B806F62-6371-47C2-BD73-87DCBC0E9DC9 Q37810251-FDE2D8AE-F6B8-4847-9B60-6565BCC665F3 Q37848311-15751ADA-296D-4448-8601-146DB9A9C0D0 Q37876853-EF1CDFE4-7448-400A-AE36-9E9664C5BD23 Q38395698-EAC3684C-B41B-4496-BE78-BBD31DA51A5C Q41985686-87296EB0-EDA1-4377-9097-7487B4A569E1

P2860

Urinary biomarker profiling in transitional cell carcinoma.

http://www.wikidata.org/entity/Q51932949

description

2006 nî lūn-bûn

@nan

2006年の論文

@ja

2006年学术文章

@wuu

2006年学术文章

@zh

2006年学术文章

@zh-cn

2006年学术文章

@zh-hans

2006年学术文章

@zh-my

2006年学术文章

@zh-sg

2006年學術文章

@yue

2006年學術文章

@zh-hant

name

Urinary biomarker profiling in transitional cell carcinoma.

@en

Urinary biomarker profiling in transitional cell carcinoma.

@en-gb

Urinary biomarker profiling in transitional cell carcinoma.

@nl

type

label

Urinary biomarker profiling in transitional cell carcinoma.

@en

Urinary biomarker profiling in transitional cell carcinoma.

@en-gb

Urinary biomarker profiling in transitional cell carcinoma.

@nl

prefLabel

Urinary biomarker profiling in transitional cell carcinoma.

@en

Urinary biomarker profiling in transitional cell carcinoma.

@en-gb

Urinary biomarker profiling in transitional cell carcinoma.

@nl

P1433

Q51932949-D958F647-3566-46D3-A4E7-F4BB7B882FEF

P1476

Q51932949-A0D0FD47-94AD-40CC-AE46-110096575CF3

P2093

Q51932949-01EA8E79-723E-4192-A441-9BCF93D119E2

Q51932949-03534045-C133-4AAF-ADE7-A5FE577DED08

Q51932949-6CDA3ED1-1289-4017-964B-DD8148639441

Q51932949-77E585EF-6C89-4EF6-B187-1630DAD00D97

Q51932949-8BE2D42E-26B9-4728-A4E0-B3247AFEE0D0

Q51932949-A05C2F9C-B798-476F-AE92-810DA3499B4B

Q51932949-B7759167-5796-42DB-A388-B3483146C4A4

Q51932949-ECC36B72-1342-4D20-8B20-F66AC5E258F1

P2860

Q51932949-6EF05FBA-1F69-41A1-9D87-1CBC887121A6

Q51932949-71D4D887-C3B5-4CB8-BD6D-00B4064AB7E0

Q51932949-A79AB1C3-4AE1-41E3-804A-70365B2D98E9

P304

Q51932949-0A7005B9-AF05-4489-97F5-32DB6FC8189E

P31

Q51932949-C33C3C52-9C2A-47EF-AF5A-1F6687B3BFA4

P356

Q51932949-AE16A2C5-A6E0-4BB6-A837-7FC57A839B71

P433

Q51932949-245446E0-B2E9-4075-852E-85A7429C60F0

P478

Q51932949-878D1D25-10FE-4FBF-8AD0-58F628D5F493

P50

Q51932949-32E64900-10D2-4DA1-B588-51E16ACBD1AF

Q51932949-7268146E-0AC1-433C-9618-477C74D27B59

Q51932949-F45997ED-1084-48CB-A7F6-F2D895BC059B

P577

Q51932949-61152826-8EE1-4564-A436-B684A5D39930

P5875

Q51932949-68C9A688-ED68-4D50-9DB3-86135DBAAFDC

P698

Q51932949-E10C9364-FECA-4270-B5FE-A373D3210843

P921

Q51932949-B33A9E85-91F7-44B9-BC72-AB36CBC34226

P356

P1433

International Journal of Cancer

P1476

Urinary biomarker profiling in transitional cell carcinoma.

@en

P2093

Anthea J Stanley

http://www.w3.org/2001/XMLSchema#string

Douglas Thompson

http://www.w3.org/2001/XMLSchema#string

Ian Eardley

http://www.w3.org/2001/XMLSchema#string

Margaret A Knowles

http://www.w3.org/2001/XMLSchema#string

Mark Rogers

http://www.w3.org/2001/XMLSchema#string

Nicholas P Munro

http://www.w3.org/2001/XMLSchema#string

Patricia Harnden

http://www.w3.org/2001/XMLSchema#string

Paul Clarke

http://www.w3.org/2001/XMLSchema#string

P2860

Development of a novel proteomic approach for the detection of transitional cell carcinoma of the bladder in urine

An integrated approach to the detection of colorectal cancer utilizing proteomics and bioinformatics.

Human alpha-defensins HNPs-1, -2, and -3 in renal cell carcinoma: influences on tumor cell proliferation.

P304

2642-2650

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/IJC.22238

http://www.w3.org/2001/XMLSchema#string

P433

11

http://www.w3.org/2001/XMLSchema#string

P478

119

http://www.w3.org/2001/XMLSchema#string

P50

Rosamonde Elizabeth Banks

David A. Cairns

P577

2006-12-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

6803621

http://www.w3.org/2001/XMLSchema#string

P698

16991122

http://www.w3.org/2001/XMLSchema#string

P921